Insider Transactions
Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
---|---|---|---|---|---|---|---|
May 08, 2015 | SVP, Pharmacology & Biology | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 9,313 | $10.80 | 15,687 | |
May 08, 2015 | VP Clinical Ops & Data Mgmt | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 9,305 | $10.80 | 15,695 | |
Oct 01, 2009 | Chief Financial Officer | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 220 | $8.75 | 32,075 | |
Sep 01, 2009 | Chief Financial Officer | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 220 | $9.83 | 32,295 | |
Aug 01, 2009 | Chief Financial Officer | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 220 | $11.39 | 32,515 | |
Jul 01, 2009 | Chief Financial Officer | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 220 | $11.45 | 32,735 | |
Jun 01, 2009 | Chief Financial Officer | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 220 | $6.64 | 32,955 | |
May 01, 2009 | Chief Financial Officer | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 220 | $8.95 | 33,175 | |
Apr 01, 2009 | Chief Financial Officer | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 220 | $9.13 | 33,395 | |
Mar 01, 2009 | Chief Financial Officer | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 220 | $8.06 | 33,615 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.